Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 8.58
- Piotroski Score 7.00
- Grade Buy
- Symbol (ZTS)
- Company Zoetis Inc.
- Price $195.43
- Changes Percentage (0.32%)
- Change $0.62
- Day Low $193.58
- Day High $196.00
- Year High $201.92
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
- Last Earnings 05/22/2024
- Ex-Dividend for 5/16 Dividend 07/18/2024
- Dividend Payable 09/04/2024
- Today N/A
- Next Earnings (Estimated) 11/03/2024
- Fiscal Year End N/A
- Average Stock Price Target $230.00
- High Stock Price Target $254.00
- Low Stock Price Target $195.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $5.20
- Trailing P/E Ratio 34.02
- Forward P/E Ratio 34.02
- P/E Growth 34.02
- Net Income $2.34 B
Income Statement
Quarterly
Annual
Latest News of ZTS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Jim Cramer Likes Zoetis Inc (NYSE:ZTS) "Very Much"
The list of Jim Cramer's top stock picks for Q4 includes Zoetis Inc (NYSE:ZTS), ranking 4th. Cramer advises investors to capitalize on short-term rallies and take profits when stocks rise....
By Yahoo! Finance | 2 days ago -
Zoetis' (NYSE:ZTS) investors will be pleased with their favorable 58% return over the last five years
Investing for long-term profit involves monitoring share price performance. Zoetis Inc. has seen a 52% increase in the last five years, with a 6.0% rise in the past year. Despite positive earnings gro...
By Yahoo! Finance | 2 weeks ago -
Is Now The Time To Put Zoetis (NYSE:ZTS) On Your Watchlist?
Investors often buy shares in loss-making companies with a promising story, but the risk of continuous losses is high. Opting for profitable companies like Zoetis (NYSE:ZTS) can provide long-term valu...
By Yahoo! Finance | 1 month ago
